keyword
https://read.qxmd.com/read/38657100/extracellular-vesicles-containing-circmybl1-induce-cd44-in-adenoid-cystic-carcinoma-cells-and-pulmonary-endothelial-cells-to-promote-lung-metastasis
#1
JOURNAL ARTICLE
Min Fu, Qian Gao, Mian Xiao, Rui-Feng Li, Xin-Yi Sun, Sheng-Lin Li, Xin Peng, Xi-Yuan Ge
Adenoid cystic carcinoma (ACC) is a rare malignant epithelial neoplasm that arises in secretory glands and commonly metastasizes to the lungs. MYBL1 is frequently overexpressed in ACC and has been suggested to be a driver of the disease. Here, we identified a circRNA derived from MYBL1 pre-mRNA that accompanied overexpression of MYBL1 in ACC. Overexpression of circMYBL1 was correlated with increased lung metastasis and poor overall survival in ACC patients. Ectopic circMYBL1 overexpression promoted malignant phenotypes and lung metastasis of ACC cells...
April 24, 2024: Cancer Research
https://read.qxmd.com/read/38656242/impact-of-anti-angiogenic-drugs-on-severity-of-covid-19-in-patients-with-non-small-cell-lung-cancer
#2
JOURNAL ARTICLE
Sujuan Peng, Hongxiang Huang, Jinhong Chen, Xinjing Ding, Xie Zhu, Yangyang Liu, Li Chen, Zhihui Lu
Introduction: The 2019 coronavirus disease (COVID-19) pandemic has reshaped oncology practice, but the impact of anti-angiogenic drugs on the severity of COVID-19 in patients with non-small cell lung cancer (NSCLC) remains unclear. Patients and Methods: We carried out a retrospective study involving 166 consecutive patients with NSCLC who were positive for COVID-19, aiming to determine the effects of anti-angiogenic drugs on disease severity, as defined by severe/critical symptoms, intensive care unit (ICU) admission/intubation, and mortality outcomes...
2024: Technology in Cancer Research & Treatment
https://read.qxmd.com/read/38655736/exploring-cytologic-features-and-potential-diagnostic-challenges-of-metastatic-nut-carcinoma-to-the-parotid-gland-a-case-report-and-a-comprehensive-literature-review
#3
JOURNAL ARTICLE
Crystal Y Li, Salih Salihoglu, Francisco J Civantos, Jaylou M Velez Torres
NUT carcinoma (NC) is a highly aggressive, poorly differentiated carcinoma that harbors a t(15:19) translocation, leading to the fusion of the NUTM1 gene. While the upper aerodigestive tract along the midline (head, neck, thorax, and mediastinum) is commonly reported as the primary site of NC, subsequent cases have emerged in diverse locations. Achieving a definitive diagnosis based solely on morphology is challenging; however, it can be achieved using immunohistochemistry (IHC) specific to the NUT antibody or by demonstrating the characteristic BRD4::NUTM1 fusion...
April 24, 2024: Diagnostic Cytopathology
https://read.qxmd.com/read/38655602/discovery-of-novel-fgfr4-inhibitors-through-a-build-up-fragment-strategy
#4
JOURNAL ARTICLE
Jihyung Kim, Chang Gyun Im, Kyujin Oh, Ji Min Lee, Fatimah Al-Rubaye, Kyung Hoon Min
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death. FGFR4 has been implicated in HCC progression, making it a promising therapeutic target. We introduce an approach for identifying novel FGFR4 inhibitors by sequentially adding fragments to a common warhead unit. This strategy resulted in the discovery of a potent inhibitor, 4c , with an IC50 of 33 nM and high selectivity among members of the FGFR family. Although further optimisation is required, our approach demonstrated the potential for discovering potent FGFR4 inhibitors for HCC treatment, and provides a useful method for obtaining hit compounds from small fragments...
December 2024: Journal of Enzyme Inhibition and Medicinal Chemistry
https://read.qxmd.com/read/38655260/mechanisms-of-resistance-to-targeted-therapy-and-immunotherapy-in-non-small-cell-lung-cancer-promising-strategies-to-overcoming-challenges
#5
REVIEW
Yuchu Xiang, Xudong Liu, Yifan Wang, Dawei Zheng, Qiuxing Meng, Lingling Jiang, Sha Yang, Sijia Zhang, Xin Zhang, Yan Liu, Bo Wang
Resistance to targeted therapy and immunotherapy in non-small cell lung cancer (NSCLC) is a significant challenge in the treatment of this disease. The mechanisms of resistance are multifactorial and include molecular target alterations and activation of alternative pathways, tumor heterogeneity and tumor microenvironment change, immune evasion, and immunosuppression. Promising strategies for overcoming resistance include the development of combination therapies, understanding the resistance mechanisms to better use novel drug targets, the identification of biomarkers, the modulation of the tumor microenvironment and so on...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38655151/retroperitoneal-laparoscopic-partial-nephrectomy-for-metanephric-adenoma-in-a-pediatric-patient-the-first-case-report-from-vietnam
#6
Vinh Hung Tran, Vo Anh Vinh Trang, Phu Phat Pham, Nguyen Hai Dang Le, Do Huu Toan Tran, Thien Tan Tri Tai Truyen
Metanephric adenoma presents as a rare benign tumor in children with differentiated diagnoses: Wilms tumor or renal cell carcinoma. When confronted with small renal tumors, whether they fall into one of these three diagnostic categories, tumor resection surgery with laparoscopic partial nephrectomy is considered a viable and effective operative approach. Herein, we report the case of an 11-year-old female patient initially diagnosed with stage T1a renal cell carcinoma with postoperative pathology results confirming metanephric adenoma...
May 2024: Urology Case Reports
https://read.qxmd.com/read/38654794/aesthetic-reconstruction-based-on-facial-subunit-principle-for-basal-cell-carcinoma-of-the-face-a-retrospective-analysis
#7
JOURNAL ARTICLE
Biswajit Mishra, Surya Mallik, Ishan Agnihotry, Jibitesh Behera
Background and objective Basal cell carcinoma (BCC) is the most common malignancy of the skin. Reconstruction of post-excisional defects in BCC should follow the subunit principle for better outcomes. The location of BCC of the face is determined based on facial units; however, very few studies have described the involvement of multiple units and multiple subunits in BCC. In this study, we aimed to provide valuable insights into the management of BCC involving various facial units and subunits, thereby contributing to improved patient care and outcomes...
March 2024: Curēus
https://read.qxmd.com/read/38654325/tumor-suppressive-mir-4732-3p-is-sorted-into-fucosylated-exosome-by-hnrnpk-to-avoid-the-inhibition-of-lung-cancer-progression
#8
JOURNAL ARTICLE
Wanzhen Zhuang, Chengxiu Liu, Yilin Hong, Yue Zheng, Minjian Huang, Haijun Tang, Lilan Zhao, Zhixin Huang, Mingshu Tu, Lili Yu, Jianlin Chen, Yi Zhang, Xiongfeng Chen, Fan Lin, Qi Gao, Chundong Yu, Yi Huang
BACKGROUND: Aberrant fucosylation observed in cancer cells contributes to an augmented release of fucosylated exosomes into the bloodstream, where miRNAs including miR-4732-3p hold promise as potential tumor biomarkers in our pilot study. However, the mechanisms underlying the sorting of miR-4732-3p into fucosylated exosomes during lung cancer progression remain poorly understood. METHODS: A fucose-captured strategy based on lentil lectin-magnetic beads was utilized to isolate fucosylated exosomes and evaluate the efficiency for capturing tumor-derived exosomes using nanoparticle tracking analysis (NTA)...
April 23, 2024: Journal of Experimental & Clinical Cancer Research: CR
https://read.qxmd.com/read/38653033/validation-of-the-lung-immune-prognostic-index-lipi-as-a-prognostic-biomarker-in-metastatic-renal-cell-carcinoma
#9
JOURNAL ARTICLE
Lucia Carril-Ajuria, Pernelle Lavaud, Cecile Dalban, Sylvie Negrier, Gwénaëlle Gravis, Robert J Motzer, Christine Chevreau, Nizar M Tannir, Stéphane Oudard, David F McDermott, Brigitte Laguerre, Hans J Hammers, Philippe Barthelemy, Elizabeth R Plimack, Delphine Borchiellini, Marine Gross-Goupil, Ruiyun Jiang, Chung-Wei Lee, Heshani de Silva, Brian I Rini, Bernard Escudier, Laurence Albigès
BACKGROUND: The Lung Immune Prognostic Index (LIPI) is associated with immune checkpoint inhibitors (ICI) outcomes across different solid tumors, particularly in non-small cell lung cancer. Data regarding the prognostic and/or predictive role of LIPI in metastatic renal cell carcinoma (mRCC) are still scarce. The aim of this study was to evaluate whether LIPI could be predictive of survival in mRCC patients. METHODS: We used patient level data from three different prospective studies (NIVOREN trial: nivolumab; TORAVA trial: VEGF/VEGFR-targeted therapy (TT); CheckMate 214: nivolumab-ipilimumab vs sunitinib)...
April 8, 2024: European Journal of Cancer
https://read.qxmd.com/read/38652741/decorin-suppresses-tumor-lymphangiogenesis-a-mechanism-to-curtail-cancer-progression
#10
JOURNAL ARTICLE
Dipon K Mondal, Christopher Xie, Gabriel J Pascal, Simone Buraschi, Renato V Iozzo
The complex interplay between malignant cells and the cellular and molecular components of the tumor stroma is a key aspect of cancer growth and development. These tumor-host interactions are often affected by soluble bioactive molecules such as proteoglycans. Decorin, an archetypical small leucine-rich proteoglycan primarily expressed by stromal cells, affects cancer growth in its soluble form by interacting with several receptor tyrosine kinases (RTK). Overall, decorin leads to a context-dependent and protracted cessation of oncogenic RTK activity by attenuating their ability to drive a prosurvival program and to sustain a proangiogenic network...
April 30, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38652128/comparative-investigation-of-neoadjuvant-immunotherapy-versus-adjuvant-immunotherapy-in-perioperative-patients-with-cancer-a-global-scale-cross-sectional-large-sample-informatics-study
#11
JOURNAL ARTICLE
Song-Bin Guo, Le-Sheng Hu, Wei-Juan Huang, Zhen-Zhong Zhou, Hui-Yan Luo, Xiao-Peng Tian
BACKGROUND: Neoadjuvant and adjuvant immunotherapies for cancer have evolved through a series of remarkable and critical research advances; however, addressing their similarities and differences is imperative in clinical practice. Therefore, this study aimed to examine their similarities and differences from the perspective of informatics analysis. METHODS: This cross-sectional study retrospectively analyzed extensive relevant studies published between 2014 and 2023 using stringent search criteria, excluding non-peer-reviewed and non-English documents...
April 23, 2024: International Journal of Surgery
https://read.qxmd.com/read/38652093/identification-of-ppar-related-differentially-expressed-genes-liver-hepatocellular-carcinoma-and-construction-of-a-prognostic-model-based-on-data-analysis-and-molecular-docking
#12
JOURNAL ARTICLE
Yumeng Wang, Shuqiang Li, Zihang Liu, Xuanzheng Li, Yifan Yu, Hao Liu
Liver hepatocellular carcinoma (LIHC) is a significant global health issue with limited treatment options. In this study, single-cell RNA sequencing (scRNA-seq) data were used to explore the molecular mechanisms of LIHC development and identify potential targets for therapy. The expression of peroxisome proliferator-activated receptors (PPAR)-related genes was analysed in LIHC samples, and primary cell populations, including natural killer cells, T cells, B cells, myeloid cells, endothelial cells, fibroblasts and hepatocytes, were identified...
April 2024: Journal of Cellular and Molecular Medicine
https://read.qxmd.com/read/38651850/mycosis-fungoides-with-large-cell-transformation-cd30-and-b-cell-chronic-lymphocytic-leukemia
#13
JOURNAL ARTICLE
Mikela Petković, Ivana Ilić, Ružica Jurakić Tončić, Ivo Radman-Livaja, Romana Čeović
Mycosis fugnoides (MF) is an indolent cutaneous T-cell lymphoma (CTLC) and is the most common of all cutaneous lymphomas. An increased risk for developing a second primary malignancy in patients with CTCL has been described in several studies, with a range from 1.04 to 2.4 (1-4). Caucasian males are at higher risk for MF development. MF is often diagnosed at ages between 55 and 67 years, and second malignancy usually occurs 5 or 6 years after the diagnosis of MF was established (5). The most common second primary malignancies include non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), lung carcinoma, bladder carcinoma, and melanoma...
December 2023: Acta Dermatovenerologica Croatica: ADC
https://read.qxmd.com/read/38651156/anlotinib-in-chinese-patients-aged-%C3%A2-70-years-with-advanced-non-squamous-non-small-cell-lung-cancer-without-prior-chemotherapy-a-multicenter-single-arm-pilot-trial
#14
JOURNAL ARTICLE
Da Zhao, Zhengguo Li, Xinli Hou, Lei Yang, Zeng Li, Li Yan, Hongling Li, Hua Liu, Xiaoping Liu, Feixue Song, Guixiang Li, Yu Zhang, Xiaoming Hou
BACKGROUND: Based on pharmacoeconomics, drug availability and actual treatment, optimal treatment regimens for Chinese non-small-cell lung carcinoma (NSCLC) patients over 70 years old are needed. METHODS: This multicenter, single-arm pilot trial enrolled patients with advanced non-squamous NSCLC who refused systemic chemotherapy. Eligible patients received anlotinib (12 mg/day, d1-14, Q3W) until disease progression, intolerant toxicities, or withdrawal from the study...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38650632/activation-of-p53-signaling-and-regression-of-breast-and-prostate-carcinoma-cells-by-spirooxindole-benzimidazole-small-molecules
#15
JOURNAL ARTICLE
Assem Barakat, Saeed Alshahrani, Abdullah Mohammed Al-Majid, Abdullah Saleh Alamary, Matti Haukka, Marwa M Abu-Serie, Alexander Dömling, Luis R Domingo, Yaseen A M M Elshaier
This study discusses the synthesis and use of a new library of spirooxindole-benzimidazole compounds as inhibitors of the signal transducer and activator of p53, a protein involved in regulating cell growth and cancer prevention. The text includes the scientific details of the [3 + 2] cycloaddition (32CA) reaction between azomethine ylide 7a and ethylene 3a within the framework of Molecular Electron Density Theory. The mechanism of the 32CA reaction proceeds through a two-stage one-step process, with emphasis on the highly asynchronous transition state structure...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38650538/a-case-report-of-loss-of-thyroid-transcription-factor-1-expression-in-lung-adenocarcinoma-ebus-fna
#16
JOURNAL ARTICLE
Hitesh Mathew, Ros Bartle-Jones
We present a case report of a 76-year-old male with a histologically confirmed KRAS mutated, thyroid transcription factor 1 (TTF1) positive, grade 1, mucinous adenocarcinoma with cytologically difficult to interpret lymph node metastasis showing loss of TTF1 expression and overlapping features with goblet cell hyperplasia. The case highlights the importance of molecular testing in aiding diagnosis and guiding treatment of non-small cell lung carcinomas (NSCLC).
April 23, 2024: Diagnostic Cytopathology
https://read.qxmd.com/read/38649621/merkel-cell-carcinoma-integrating-epidemiology-immunology-and-therapeutic-updates
#17
REVIEW
Jürgen C Becker, Andreas Stang, David Schrama, Selma Ugurel
Merkel cell carcinoma (MCC) is a rare skin cancer characterized by neuroendocrine differentiation. Its carcinogenesis is based either on the integration of the Merkel cell polyomavirus or on ultraviolet (UV) mutagenesis, both of which lead to high immunogenicity either through the expression of viral proteins or neoantigens. Despite this immunogenicity resulting from viral or UV-associated carcinogenesis, it exhibits highly aggressive behavior. However, owing to the rarity of MCC and the lack of epidemiologic registries with detailed clinical data, there is some uncertainty regarding the spontaneous course of the disease...
April 22, 2024: American Journal of Clinical Dermatology
https://read.qxmd.com/read/38648945/cost-effectiveness-analysis-of-the-clear-cell-likelihood-score-against-renal-mass-biopsy-for-evaluating-small-renal-masses
#18
JOURNAL ARTICLE
Katherina Y Chen, Moritz J Lange, Jessica X Qiu, Drew Lambert, Ayman Mithqal, Tracey L Krupski, Noah S Schenkman, Jennifer M Lobo
OBJECTIVE: To examine the cost-effectiveness of the clear cell likelihood score compared to renal mass biopsy alone. METHODS: The clear cell likelihood score, a new grading system based on multiparametric magnetic resonance imaging, has been proposed as a possible alternative to percutaneous renal mass biopsy for identifying clear cell renal carcinoma in small renal masses and expediting treatment of high-risk patients. A decision analysis model was developed to compare a renal mass biopsy strategy where all patients undergo biopsy and a clear cell likelihood score strategy where only patients that received an indeterminant score of 3 undergo biopsy...
April 20, 2024: Urology
https://read.qxmd.com/read/38648704/hru-net-a-high-resolution-convolutional-neural-network-for-esophageal-cancer-radiotherapy-target-segmentation
#19
JOURNAL ARTICLE
Muwei Jian, Chen Tao, Ronghua Wu, Haoran Zhang, Xiaoguang Li, Rui Wang, Yanlei Wang, Lizhi Peng, Jian Zhu
BACKGROUND AND OBJECTIVE: The effective segmentation of esophageal squamous carcinoma lesions in CT scans is significant for auxiliary diagnosis and treatment. However, accurate lesion segmentation is still a challenging task due to the irregular form of the esophagus and small size, the inconsistency of spatio-temporal structure, and low contrast of esophagus and its peripheral tissues in medical images. The objective of this study is to improve the segmentation effect of esophageal squamous cell carcinoma lesions...
April 14, 2024: Computer Methods and Programs in Biomedicine
https://read.qxmd.com/read/38647725/the-ras-related-protein-rab22a-interacts-with-hypoxia-inducible-factor-1-alpha-hif-1%C3%AE-in-mda-mb-231-breast-cancer-cells-in-hypoxia
#20
JOURNAL ARTICLE
Nikolaos A Papanikolaou, Maria Kakavoulia, Christos Ladias, Athanasios G Papavassiliou
BACKGROUND: Recent studies suggest that hypoxia-inducible factor 1-alpha (HIF-1α) and the small GTPase protein Ras-related protein Rab-22 A (RAB22A) may be colocalized in the cytoplasm and that as a conequence they may enhance the formation of microvesicles in breast cancer cells under hypoxia. Therefore, we sought to determine whether these two proteins are present in intracellular complexes in breast carcinoma cells. METHODS AND RESULTS: Evaluation using molecular docking indicated that HIF-1α and RAB22A interact with each other...
April 22, 2024: Molecular Biology Reports
keyword
keyword
24892
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.